January 23, 2026

Record Reports Strong Q3 Growth Driven by Net Flows and Asset Gains – Edison Investment Research

Record plc reports strong Q3 growth with AUM reaching $115.9bn, driven by $3.3bn net flows, according to Edison Investment Research...

Differentiated portfolio positioning among UK investment trusts: New Research 

New research from Kepler Trust Intelligence examines Fidelity Asian Values, highlighting how its valuation-led approach has resulted in a highly differentiated portfolio positioning...

AI power demand puts uranium in investor spotlight

AI’s energy demands are pushing uranium into a new phase of strategic investor interest...

Investor capital flows hold up mainland China equities

China’s stock market is attracting fresh capital despite regulatory caution, with investor focus turning to metals, space and selective growth themes...

Emergent BioSolutions Inc. (EBS) Stock Analysis: Is the 11.66% Upside Worth the Risk?

Emergent BioSolutions Inc. (NYSE: EBS), the Maryland-based life sciences company, is drawing attention from investors with its potential upside of 11.66%. Known for its extensive portfolio of preparedness and response..

Rapport Therapeutics, Inc. (RAPP): Investor Outlook with an 87% Potential Upside

Rapport Therapeutics, Inc. (NASDAQ: RAPP) is rapidly making waves in the biotechnology sector with its focus on developing breakthrough therapies for central nervous system (CNS) disorders. With a market capitalization..

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring an 81.88% Potential Upside

AngioDynamics, Inc. (NASDAQ: ANGO), a key player in the medical technology sector, has caught the eye of investors with its compelling growth potential. With a market capitalization of $438.14 million,..

Enhabit, Inc. (EHAB) Stock Analysis: Exploring a 5.39% Potential Upside in Healthcare

As Enhabit, Inc. (EHAB) continues to solidify its presence in the healthcare sector, investors are closely watching its performance within the medical care facilities industry. Based in Dallas, Texas, Enhabit..

PureTech Health plc (PRTC): Biotechnology Gem with a Staggering Revenue Growth of 542.70%

PureTech Health plc (PRTC) is emerging as a standout player in the biotechnology sector, captivating the attention of investors with its remarkable revenue growth and cutting-edge innovations. Based in Boston,..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating Healthcare with Revenue Growth and a Cautious Outlook

InnovAge Holding Corp. (NASDAQ: INNV), operating within the healthcare sector as a provider of medical care facilities, has been capturing attention with its distinct approach to senior care. Headquartered in..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring a Potential 81% Upside

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a player in the healthcare sector’s medical devices industry, is making waves with its innovative solutions for bunion correction and midfoot deformities. Based in..

Castle Biosciences, Inc. (CSTL) Stock Analysis: A Healthcare Innovator with Strong Buy Ratings and 9.13% Upside Potential

Castle Biosciences, Inc. (NASDAQ: CSTL) stands out in the healthcare sector, specifically within the diagnostics and research industry. Based in Friendswood, Texas, and boasting a market capitalization of $1.23 billion,..

Prothena Corporation plc (PRTA) Stock Analysis: Evaluating a Potential 96.65% Upside

Prothena Corporation plc (NASDAQ: PRTA), a biotechnology company based in Dublin, Ireland, is gaining attention in the healthcare sector with a notable potential upside of nearly 96.65% according to analyst..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: Exploring a Potential 23% Upside in the Biotech Sector

Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a clinical-stage biotechnology company, has been making waves in the biotech sector with its innovative approach to treating severe autoimmune and inflammatory diseases. With a..

Celcuity Inc. (CELC) Stock Analysis: Exploring the Biotechnology Innovator’s Growth Potential

Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, stands at the forefront of developing targeted therapies for the treatment of solid tumors. With a market capitalization of $5.13 billion, Celcuity..

Kamada Ltd. (KMDA) Stock Analysis: Exploring a 62.91% Upside Potential in the Healthcare Sector

Kamada Ltd. (NASDAQ: KMDA), an Israeli-based biopharmaceutical company, is capturing attention in the healthcare sector with its robust portfolio of plasma-derived protein therapeutics and a promising 62.91% potential upside. As..

Owens & Minor, Inc. (OMI): Investor Outlook Reveals 94% Potential Upside Amidst Challenging Valuation

Owens & Minor, Inc. (NYSE: OMI), a pivotal player in the U.S. healthcare landscape, operates within the medical distribution industry, focusing on providing comprehensive healthcare solutions. Despite its longstanding history..

AtaiBeckley Inc. (ATAI) Stock Analysis: A Biotech Gem with Over 200% Upside Potential

AtaiBeckley Inc. (NASDAQ: ATAI), a burgeoning player in the biotechnology sector, has captured the attention of investors with its robust pipeline and promising financial outlook. Specializing in mental health treatments,..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: 74% Potential Upside Sparks Investor Interest

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is making waves in the biotechnology sector, not just for its innovative approach to cancer resistance therapies but also for its impressive potential upside. With..

Abivax SA (ABVX): Investor Outlook on Potential 23.51% Upside and Growing Analyst Confidence

Abivax SA (ABVX), a promising player in the biotechnology sector, has caught the attention of investors with a potential upside of 23.51%, driven by strong analyst confidence and strategic advancements..

Search

Funds

January 23, 2026

Record Reports Strong Q3 Growth Driven by Net Flows and Asset Gains – Edison Investment Research

Record plc reports strong Q3 growth with AUM reaching $115.9bn, driven by $3.3bn net flows, according to Edison Investment Research...

Differentiated portfolio positioning among UK investment trusts: New Research 

New research from Kepler Trust Intelligence examines Fidelity Asian Values, highlighting how its valuation-led approach has resulted in a highly differentiated portfolio positioning...

AI power demand puts uranium in investor spotlight

AI’s energy demands are pushing uranium into a new phase of strategic investor interest...

Investor capital flows hold up mainland China equities

China’s stock market is attracting fresh capital despite regulatory caution, with investor focus turning to metals, space and selective growth themes...
Search

Funds

January 23, 2026

FTSE 100

Funds